Search filters

List of works by Steven L Barriere

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

scientific article

Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure

scientific article

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates

scientific article published on 7 October 2016

Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates

scientific article published on 14 December 2016

Bacteremic nosocomial pneumonia cases from the ATTAIN studies

scientific article published in March 2010

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

scientific article published on 20 May 2014

Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

scientific article

Efficacy of telavancin for treatment of surgical site infections

scientific article published on 13 March 2008

Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections ⬇️

scientific article published on March 13, 2012

Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections

scientific article

Late ventilator-associated pneumonia: analysis of baseline characteristics and clinical outcomes in the ATTAIN studies

scientific article published in March 2010

Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus

scientific article

Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinatio

scientific article published on 21 October 2009

Reply to Tarchini

scientific article

TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections

scientific article

Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance

scientific article

Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival.

scientific article published in June 2014

Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival

scientific article

Telavancin for the treatment of hospital-acquired pneumonia in severely ill and older patients: the ATTAIN studies.

scientific article published on 13 March 2009

Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality

scientific article published on September 2015

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens ⬇️

scientific article published on January 1, 2011

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study

scientific article

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria

scientific article

Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia

scientific article

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

scientific article published in June 2008

Paulina is supported by:

About Paulina

Help